Peptide Library

FDA-approved

Heart & blood

Desirudin

Evidence

FDA approved

Class

Direct thrombin inhibitor (recombinant hirudin)

/

Desirudin

KEY TAKEAWAY

Desirudin is a recombinant form of hirudin, a 65-amino-acid anticoagulant first found in the saliva of medicinal leeches. It is sold as Iprivask. The FDA approved desirudin (Iprivask) in 2003 to prevent deep vein thrombosis after elective hip replacement.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Direct thrombin inhibitor (recombinant hirudin)

Approved for

Preventing deep vein thrombosis after hip replacement surgery

Key fact

The FDA approved desirudin (Iprivask) in 2003 to prevent deep vein thrombosis after elective hip replacement.

Route

Subcutaneous injection

Evidence strength

FDA approved

What it is

What it is

Desirudin is a recombinant form of hirudin, a 65-amino-acid anticoagulant first found in the saliva of medicinal leeches. It is sold as Iprivask.

How it works

How it works

It binds thrombin directly and blocks it, which prevents blood clots.

Regulatory status

Regulatory status

The FDA approved desirudin (Iprivask) in 2003 to prevent deep vein thrombosis after elective hip replacement.

What it is used for

What it is used for

Preventing deep vein thrombosis after hip replacement surgery.

Side effects and risks

Side effects and risks

Bleeding is the main risk. The label carries a boxed warning for spinal or epidural hematomas.

Citations

Citations

U.S. FDA prescribing information for Desirudin. DailyMed, National Library of Medicine.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo